Item 8. Financial Statements and Supplementary Data
Item
8. Financial Statements and Supplementary Data
This
information appears following Item 15 of this Report and is incorporated herein by reference.
Item
9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure
As
previously disclosed on Form 8-K filed with the SEC on October 25, 2024, on October 21, 2024, the Audit Committee (the “Audit
Committee”) of our Board dismissed Marcum LLP (“Marcum”) as the Company’s independent registered public
accounting firm.
The
reports of Marcum on the Company’s consolidated financial statements for the fiscal years ended December 31, 2023 and 2022 did
not contain an adverse opinion or a disclaimer of opinion, and were not qualified or modified as to uncertainty, audit scope or accounting
principles.
During
the fiscal years ended December 31, 2023 and 2022, and through October 21, 2024, there have been no “disagreements” (as defined
in Item 304(a)(1)(iv) of Regulation S-K and related instructions) with Marcum on any matter of accounting principles or
practices, financial statement disclosure or auditing scope or procedure, which disagreements if not resolved to the satisfaction of
Marcum would have caused Marcum to make reference thereto in its reports on the consolidated financial statements for such years.
There
were no reportable events (as that term is described in Item 304(a)(1)(v) of Regulation S-K) during the two fiscal years ended
December 31, 2023 and 2022, or in the subsequent period through October 21, 2024.
The
Company provided Marcum with a copy of the disclosure it is making herein in response to Item 304(a) of Regulation S-K,
and requested that Marcum furnish the Company with a copy of its letter addressed to the SEC, pursuant to Item 304(a)(3) of
Regulation S-K, stating whether or not Marcum agrees with the statements related to them made by the Company in this report. A copy
of Marcum’s letter to the SEC dated October 24, 2024, is filed as Exhibit 16.1 to the Form 8-K.
On
October 21, 2024, the Audit Committee of our Board approved the engagement of MRI Moores Rowland LLP (“MRI”) as the Company’s
independent registered public accounting firm for the Company’s fiscal year ended December 31, 2024, effective October 21, 2024.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.